Real-time enrollment status for this schizophrenia clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 7:18 AM UTC
| NCT Number | NCT07038876 |
| Recruiting Status | Recruiting |
| Condition | Schizophrenia |
| Phase | Clinical Trial |
| Target Enrollment | 300 participants |
| Active Locations | 25 sites in the US |
| Sponsor | MapLight Therapeutics |
| Last Updated on CT.gov | September 24, 2025 (Sep 24, 2025) |
As of March 2, 2026: Clinical trial NCT07038876 is currently recruiting participants. This clinical trial study for schizophrenia is actively seeking new participants at 25 locations across the United States. The study is sponsored by MapLight Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07038876 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 25 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07038876 was last updated Sep 24, 2025 (September 24, 2025). HelloStudys verifies this status automatically.